The Pennant Group, Inc.

$29.64 ▼ -2.27%

2026-04-21 08:54:01

Explore The Pennant Group, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap

$1.04 B

Current Price

$29.64

52W High / Low

$35 / $21.73

Stock P/E

35.03

Book Value

$9.54

Dividend Yield

—

ROCE

6.2%

ROE

9.84%

Face Value

—

EPS

$0.84

Exp Qtr EPS

—

Sector

Healthcare

Industry

Medical Care Facilities

Employees

9,700

Beta

1.3

Debt / Equity

122.86

Current Ratio

1.14

Quick Ratio

1.14

Forward P/E

19.56

Price / Sales

1.12

Enterprise Value

$1.55 B

EV / EBITDA

25.83

EV / Revenue

1.63

Rating

Strong Buy

Target Price

$37.83

EPS Forecast (FY)

—

ABOUT

The Pennant Group, Inc. In essence, delivers a broad range of healthcare services in the United States. In essence, it conducts business across two segments, Home Health and Hospice Services, and Senior Living Services. In essence, this organization delivers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In essence, it also delivers a broad range of senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. In essence, this organization conducts operations home health, hospice, and home care agencies, as well as senior living communities in Alabama, Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. In essence, this organization was incorporated in 2019 and is headquartered in Eagle, Idaho. ROE at 9.45% based on the latest available annual data. ROCE at 6.20% using operating income and capital employed. Debt to equity stands at 1.36x. Operating margin is 6.25% on trailing numbers. Trailing twelve month sales are available in the dataset.

Pros

Core market and financial snapshot is available for screening.

Cons

Capital efficiency is modest.
Operating margin is thin.
Net margin is relatively low.
Valuation is rich on a P/E basis.

Sift Stocks

S.No.	Name	Price	P.E.	Market Cap	Div Yld %	ROCE	ROE	52Week High/ Low	Book Value
1.	U.S. Physical Therapy, Inc.	$75.72	28.66	$431.66 M	2.43%	7.55%	7.59%	$93.5 / $64.99	$31.5
2.	Select Medical Holdings Corporation	$16.41	13.93	$2.04 B	1.52%	6.91%	10.64%	$18.61 / $11.65	$13.75
3.	Encompass Health Corporation	$103.27	18.68	$10.28 B	0.72%	16.84%	24.82%	$127.99 / $92.77	$24.38
4.	Enhabit, Inc.	$13.72	—	$702.56 M	—	6.13%	-0.46%	$14.22 / $6.47	$10.53
5.	Surgery Partners, Inc.	$14.31	—	$1.85 B	—	6.27%	2.76%	$24.18 / $11.41	$13.37
6.	Chemed Corporation	$385.77	19.4	$5.15 B	0.62%	27.27%	25.28%	$593.8 / $365.2	$71.44
7.	Option Care Health, Inc.	$28.77	21.68	$4.5 B	—	12.87%	15.2%	$36.8 / $24.24	$8.46

Quarterly Results

Figures shown in M / B

	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024
Sales	289.32 M	229.04 M	219.5 M	209.84 M	188.89 M
Operating Profit	17.57 M	10.19 M	10.48 M	12.65 M	9.3 M
Net Profit	8.64 M	6.08 M	7.08 M	7.78 M	5.76 M
EPS in Rs	0.25	0.18	0.2	0.22	0.17

Profit & Loss

Figures shown in M / B

	2025	2024	2023	2022
Sales	947.71 M	695.24 M	544.89 M	473.24 M
Operating Profit	50.89 M	37.43 M	25.24 M	19.7 M
Net Profit	29.58 M	22.56 M	13.38 M	6.64 M
EPS in Rs	0.85	0.65	0.39	0.19

Balance Sheet

Figures shown in M / B

	2025	2024	2023	2022
Total Assets	968.18 M	679.52 M	539.69 M	512.12 M
Total Liabilities	593.93 M	367.56 M	394.18 M	386.46 M
Equity	332.6 M	293.28 M	140.34 M	121.01 M
Current Assets	167.41 M	122.86 M	80.08 M	73.82 M
Current Liabilities	147.26 M	101.7 M	71.55 M	70.25 M

Cash Flow

Last available yearly cash flow history

	2025	2024	2023	2022
Operating CF	48.29 M	39.3 M	33.09 M	9.04 M
Investing CF	-227.97 M	-70.68 M	-30.22 M	-24.24 M
Financing CF	172.46 M	49.57 M	1.11 M	12.08 M
Free CF	36.26 M	30.31 M	24.98 M	-5.13 M
Capex	-12.04 M	-8.99 M	-8.11 M	-14.17 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

	2025	2024	2023	2022
Revenue Growth %	36.31%	27.59%	15.14%	—
Earnings Growth %	31.11%	68.61%	101.4%	—
Profit Margin %	3.12%	3.24%	2.46%	1.4%
Operating Margin %	5.37%	5.38%	4.63%	4.16%
Gross Margin %	13.77%	13.49%	12.3%	12.38%
EBITDA Margin %	6.42%	6.39%	5.62%	3.72%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

No dividend history available.

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Holder Name	Type	Shares	Value	% Out	Report Date
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total	Mutual Fund	0.34 M	$10.17 M	0.01%	2026-02-28
iShares Trust-iShares Russell 2000 ETF	Mutual Fund	0.8 M	$23.82 M	0.02%	2026-01-31
First Eagle Funds-First Eagle Small Cap Opportunity Fund	Mutual Fund	0.37 M	$11.04 M	0.01%	2026-01-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	Mutual Fund	0.33 M	$9.72 M	0.01%	2026-01-31
Van Berkom & Associates Inc.	Institutional	3.12 M	$92.4 M	0.09%	2025-12-31
Blackrock Inc.	Institutional	2.71 M	$80.5 M	0.08%	2025-12-31
Vanguard Group Inc	Institutional	2.05 M	$60.8 M	0.06%	2025-12-31
Paradigm Capital Management	Institutional	1.41 M	$41.9 M	0.04%	2025-12-31
Ophir Asset Management Pty Ltd	Institutional	1.33 M	$39.35 M	0.04%	2025-12-31
FMR, LLC	Institutional	1.04 M	$30.94 M	0.03%	2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	Mutual Fund	1.03 M	$30.63 M	0.03%	2025-12-31
Geode Capital Management, LLC	Institutional	0.82 M	$24.32 M	0.02%	2025-12-31
Wellington Management Group, LLP	Institutional	0.82 M	$24.26 M	0.02%	2025-12-31
Dimensional Fund Advisors LP	Institutional	0.8 M	$23.84 M	0.02%	2025-12-31
State Street Corporation	Institutional	0.78 M	$23.28 M	0.02%	2025-12-31